Acute Phase Reactants

Acute phase reactants
http://www.uic.edu/

Clinical Chemistry
Keri Brophy-Martinez
http://www.austincc.edu/

Nature of the Immune System
http://www.austincc.edu/

Rheumatoid Arthritis
Praharsha R. Menon
http://www.fpm.emory.edu/

C-Reactive Proteins
Amy Alread
http://www.milligan.edu/

Evaluation of Laboratory Data in Nutrition Assessment
Cinda S. Chima, MS, RD
http://www3.uakron.edu/

General or Nonspecific Host Immune Defense Mechanisms
http://pages.cabrini.edu/

The Immune System
http://navigator.medschool.pitt.edu/

Mechanisms of Immunity
http://webmedia.unmc.edu/

Approach to the Patient with ANEMIA
Lisa Mohr, MD, Mike Tuggy, MD
http://www.fammed.washington.edu/

Overview of Rheumatoid Arthritis
Naureen Mirza, MD
https://cbase.som.sunysb.edu/

Iron Repletion in ESRD
Saleem Bharmal
http://medicine.med.nyu.edu

Nutrition Support of the Hospitalized Patient Therapeutic Priorities
http://www.med.unc.edu/

First Foundations in Pathology
Paul G. Koles, MD
http://www.med.wright.edu/

Effect of procalcitonin-based guidelines vs standard guidelines
Ria Dancel, MD
https://medicine.med.unc.edu/


249 Published articles on Acute Phase Reactants

1. Value of acute-phase reactants in monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis.
2. Increased levels of BAFF in patients with systemic lupus erythematosus are associated with acute-phase reactants, independent of BAFF genetics: a case-control study.
3. HLA-DRB1 shared epitope genotyping using the revised classification and its association with circulating autoantibodies, acute phase reactants, cytokines and clinical indices of disease activity in a cohort of South African rheumatoid arthritis patients.
4. C-reactive protein and complement components but not other acute-phase reactants discriminate between clinical subsets and organ damage in systemic lupus erythematosus.
5. Serum levels of HMGB1 in postmenopausal patients with rheumatoid arthritis: associations with proinflammatory cytokines, acute-phase reactants, and clinical disease characteristics.
6. Chemically induced breast tumors in rats are detectable in early stages by contrast enhanced magnetic resonance imaging but not by changes in the acute-phase reactants in serum.
7. Diagnostic and predictive value of acute-phase reactants in adult undifferentiated peripheral inflammatory arthritis: a systematic review.
8. Acute phase reactants predict the risk of amputation in diabetic foot infection.
9. Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: the role of acute-phase reactants.
10. Relationship of Acute Phase Reactants and Fat Accumulation during Treatment for Tuberculosis.
11. Acute-phase reactants and a supplemental diagnostic aid for Kawasaki disease.
12. Acute phase reactants in patients with coronary slow flow phenomenon.
13. A modified rheumatoid arthritis disease activity score without acute-phase reactants (mDAS28) for epidemiological research.
14. Potential additional effect of omentectomy on metabolic syndrome, acute-phase reactants, and inflammatory mediators in grade III obese patients undergoing laparoscopic Roux-en-Y gastric bypass: a randomized trial.
15. The story behind the acute-phase reactants.
16. Associations of acute-phase reactants with metabolic syndrome in middle-aged overweight or obese people.
17. Comparison of early and late changes in immunoglobulins and acute phase reactants after laparoscopic adjustable gastric banding in patients with morbid obesity.
18. Circulating cytokine profiles and their relationships with autoantibodies, acute phase reactants, and disease activity in patients with rheumatoid arthritis.
19. [Various acute phase reactants in different types of proliferative diseases of the uterine appendages].
20. Do acute-phase reactants predict response to glucocorticoid therapy in retroperitoneal fibrosis?
21. Evaluation of composite measures of treatment response without acute-phase reactants in patients with rheumatoid arthritis.
22. Effects of one year simvastatin and atorvastatin treatments on acute phase reactants in uncontrolled type 2 diabetic patients.
23. The effects of combined therapy of rheumatoid arthritis on the acute phase reactants.
24. Utility of interleukin-12 and interleukin-10 in comparison with other cytokines and acute-phase reactants in the diagnosis of neonatal sepsis.
25. Identification of acute phase reactants and cytokines useful for monitoring infliximab therapy in ankylosing spondylitis.
26. Acute-phase reactants after paediatric cardiac arrest. Procalcitonin as marker of immediate outcome.
27. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.
28. Rapid and deep control of inflammation in rheumatoid arthritis with infliximab and its correlation with acute-phase reactants.
29. Concentrations of the acute phase reactants high-sensitive C-reactive protein and YKL-40 and of interleukin-6 before and after treatment in patients with acromegaly and growth hormone deficiency.
30. Genetics and genomics of hepatic acute phase reactants: a mini-review.
31. Relation of antioxidants and acute-phase reactants in patients receiving hemodialysis.
32. The value of the levels of acute phase reactants for the prediction of familial Mediterranean fever associated amyloidosis: a case control study.
33. Positive effect of dietary soy in ESRD patients with systemic inflammation--correlation between blood levels of the soy isoflavones and the acute-phase reactants.
34. [Acute-phase reactants and markers of inflammation in venous thromboembolic disease: correlation with clinical and evolution parameters].
35. Rapid pulmonary expression of acute-phase reactants after local lipopolysaccharide exposure in mice is followed by an interleukin-6 mediated systemic acute-phase response.
36. Inflammatory biomarkers in acute coronary syndromes: part II: acute-phase reactants and biomarkers of endothelial cell activation.
37. Retinol-binding protein, acute phase reactants and Helicobacter pylori infection in patients with gastric adenocarcinoma.
38. Acute phase reactants predict mitral regurgitation following mitral valvuloplasty.
39. Use of serum amyloid A and other acute phase reactants to monitor the inflammatory response after castration in horses: a field study.
40. Acute-phase reactants during murine tuberculosis: unknown dimensions and new frontiers.
41. Acute-phase reactants and coronary heart disease.
42. Association of acute-phase reactants with arterial stiffness in patients with type 2 diabetes mellitus.
43. Acute phase reactants, challenge in the near future of animal production and veterinary medicine.
44. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score.
45. Dramatic elevations of interleukin-6 and acute-phase reactants in athletes participating in the ultradistance foot race spartathlon: severe systemic inflammation and lipid and lipoprotein changes in protracted exercise.
46. Relationship of granulocyte colony stimulating factor with other acute phase reactants in man.
47. The serial changes in plasma homocysteine levels and it's relationship with acute phase reactants in early postmyocardial infarction period.
48. Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: a prospective followup study.
49. Acute phase reactants in allergic airway disease.
50. Blood levels of acute phase reactants with traffic accidents.
51. [Idiopathic retroperitoneal fibrosis: a case report without increased levels of acute-phase reactants. Noninvasive diagnosis and treatment].
52. Relationship between some acute phase reactants and the Bath Ankylosing Spondylitis Disease Activity Index in patients with ankylosing spondylitis.
53. Acute phase reactants and cytokine levels in unilateral community-acquired pneumonia.
54. Association between acute-phase reactants and advanced glycation end products in type 2 diabetes.
55. [Tumoral markers and acute-phase reactants in the diagnosis of pancreatic cancer].
56. Preprocedural serum levels of acute-phase reactants and prognosis after percutaneous coronary intervention.
57. High-dose biotin may down-regulate hepatic expression of acute phase reactants by mimicking the physiological role of nitric oxide.
58. Profiles of the acute-phase reactants C-reactive protein and ferritin related to the disease course of patients with systemic lupus erythematosus.
59. Plasminogen activator inhibitor-1 (PAI-1) activity post myocardial infarction: the role of acute phase reactants, insulin-like molecules and promoter (4G/5G) polymorphism in the PAI-1 gene.
60. Relationship between advanced glycoxidation end products, inflammatory markers/acute-phase reactants, and some autoantibodies in chronic hemodialysis patients.
61. Low vitamin B(6) plasma levels, a risk factor for thrombosis, in inflammatory bowel disease: role of inflammation and correlation with acute phase reactants.
62. Serum lipids act as inverse acute phase reactants and are falsely low in patients with critical limb ischemia.
63. Acute phase reactants in hemodialysis and renal transplantation.
64. [Short-term prognosis of patients admitted for probable acute coronary syndrome without ST-segment elevation. Role of new myocardial damage markers and acute-phase reactants].
65. Nutritional markers, acute phase reactants and tissue inhibitor of matrix metalloproteinase 1 in elderly patients with pressure sores.
66. Acute phase reactants in patients with abdominal aortic aneurysm.
67. Coagulation indicators in chronic stable effort angina and unstable angina: relationship with acute phase reactants and clinical outcome.
68. Modulation of types I and II acute phase reactants with insulin-like growth factor-1/binding protein-3 complex in severely burned children.
69. Modulation of types I and II acute phase reactants with insulin-like growth factor-1/binding protein-3 complex in severely burned children.
70. The response of serum sialic acid and other acute phase reactants to an oral fat load in healthy humans.
71. Applications of acute phase reactants in infectious diseases.
72. [Effect of combination therapy and nonsteroidal antirheumatic agents on acute phase reactants in patients with rheumatoid arthritis].
73. Hyperglycemia-induced production of acute phase reactants in adipose tissue.
74. Predictive values of acute phase reactants, basic fetoprotein, and immunosuppressive acidic protein for staging and survival in renal cell carcinoma.
75. Hepatic regeneration induces transient acute phase reaction: systemic elevation of acute phase reactants and soluble cytokine receptors.
76. Acute-phase reactants in acute myocardial infarction: impact on 5-year prognosis.
77. Increased acute phase reactants are associated with levels of lipoproteins and increased carotid plaque volume.
78. Acute-phase reactants in infections and inflammatory diseases.
79. Comparison of postoperative acute-phase reactants in patients who underwent laparoscopic v open cholecystectomy: a randomized study.
80. Are metalloproteins and acute phase reactants associated with cardiovascular disease in end-stage renal failure?
81. [Relation between preoperative plasma levels of hypercoagulation markers and acute phase reactants in patients with rheumatoid arthritis who are candidates for hip or knee arthroplasty].
82. Equivalence of the acute phase reactants C-reactive protein, plasma viscosity, and Westergren erythrocyte sedimentation rate when used to calculate American College of Rheumatology 20% improvement criteria or the Disease Activity Score in patients with early rheumatoid arthritis. Western Consortium of Practicing Rheumatologists.
83. Heme oxygenase inhibitors transiently increase serum ferritin concentrations without altering other acute-phase reactants in man.
84. Heme and acute inflammation role in vivo of heme in the hepatic expression of positive acute-phase reactants in rats.
85. Usefulness of acute phase reactants in the diagnosis of acute infections in HIV-infected children.
86. The acute phase reaction syndrome: the acute phase reactants (a review).
87. Influence of antimicrobial chemotherapy and smoking status on the plasma concentrations of vitamin C, vitamin E, beta-carotene, acute phase reactants, iron and lipid peroxides in patients with pulmonary tuberculosis.
88. Thymic carcinoma associated with a high serum level of interleukin 6 diagnosed through the evaluation for asymptomatic elevation of acute-phase reactants.
89. [The usefulness of determining acute-phase reactants in establishing the bacterial etiology in lower respiratory tract infections].
90. Analysis of coagulation proteins as acute-phase reactants in horses with colic.
91. Cytokines and acute phase reactants during flare-up of contact allergy to gold.
92. Immunotherapy and combined assay of serum levels of carcinoembryonic antigen and acute-phase reactants.
93. Serum interleukin-6 in relation to acute-phase reactants and survival in patients with renal cell carcinoma.
94. Seasonal variations of rheological and hemostatic parameters and acute-phase reactants in young, healthy subjects.
95. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.
96. Hormonal regulation of lipoprotein(a) levels: effects of estrogen replacement therapy on lipoprotein(a) and acute phase reactants in postmenopausal women.
97. Mast cell adhesion to extracellular matrix: local effects of acute phase reactants.
98. Fever, C-reactive protein, and other acute-phase reactants during treatment of infective endocarditis.
99. Systemic acute-phase reactants, C-reactive protein and haptoglobin, in adult periodontitis.
100. Acute-phase reactants and plasma trace element concentrations in non-small cell lung cancer patients and controls.
101. Comparison of CO2 laser, electrocautery, and scalpel incisions on acute-phase reactants in rat skin.
102. [Interleukin-6 and acute phase reactants in the diagnosis of ovarian carcinoma].
103. Acute phase reactants in Alzheimer's disease.
104. Expression of beta-2-integrins and L-selectin by leukocytes and changes in acute-phase reactants in total hip replacement surgery.
105. Serum acute phase reactants and prognosis in renal cell carcinoma.
106. Blood levels of cytokines in brain-dead patients: relationship with circulating hormones and acute-phase reactants.
107. Acute-phase reactants as tumor markers.
108. Regulation of bone metabolism by the kallikrein-kinin system, the coagulation cascade, and the acute-phase reactants.
109. Interleukin-6, acute phase reactants and clinical status in ankylosing spondylitis.
110. Lectins from the colonial tunicate Clavelina picta are structurally related to acute-phase reactants from vertebrates.
111. Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants.
112. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein.
113. [The effect of an antimalarial agent (chloroquine) on acute phase reactants in patients with rheumatoid arthritis].
114. [Acute phase reactants. Their clinical usefulness].
115. Acute phase reactants and severity of homozygous sickle cell disease.
116. Tumour necrosis factor soluble receptors behave as acute phase reactants following surgery in patients with rheumatoid arthritis, chronic osteomyelitis and osteoarthritis.
117. [Acute-phase reactants in sepsis].
118. Acute-phase reactants and acute bacterial otitis media.
119. Acute phase reactants and interleukin 6 after total hip replacement. Effects of high dose corticosteroids.
120. Acute phase reactants in predicting disease outcome.
121. [The sequential changes of serum acute phase reactants in response to antituberculous chemotherapy].
122. Tissue Injury-Inducing Potential of Unmodified ECT: Serial Measurement of Acute Phase Reactants.
123. Peri- and postoperative changes in serum levels of four tumor markers and three acute phase reactants in benign and malignant gynecological diseases.
124. Acute phase reactants in neonatal bacterial infection.
125. Acute phase reactants.
126. Application of acute phase reactants during antemortem and postmortem meat inspection.
127. Proteins of the complement system and acute phase reactants in sera of patients with spinal cord injury.
128. Regulation of neutrophil function by acute phase reactants. Implications for resolution of the adult respiratory distress syndrome.
129. Acute phase reactants and risk of bacterial meningitis among febrile infants and children.
130. Acute phase reactants and circulating immune complexes in patients with ovarian carcinoma.
131. Acute phase reactants in leprosy.
132. Acute phase reactants and suppressive E-receptor factor in various groups of patients receiving autolymphocyte therapy.
133. Catecholaminergic modulation of rat acute phase reactants.
134. Elevated acute phase reactants in hemodialysis patients.
135. Serum interleukin 6, C-reactive protein and pancreatic secretory trypsin inhibitor (PSTI) as acute phase reactants after major thoraco-abdominal surgery.
136. Automated measurement of trypsin inhibitor in urine with a centrifugal analyzer: comparison with other acute phase reactants.
137. Visceral seric proteins and acute phase reactants as indicators of the state of nutrition and inflammation in children with cystic fibrosis.
138. Relationship between plasma levels of components of the fibrinolytic system and acute-phase reactants in patients with uterine malignancies.
139. Cytokines and cell growth factors, their role in the regulation of acute phase reactants.
140. [Postoperative changes in amount of granulocyte-elastase, alpha 1-antitrypsin and other acute phase reactants in blood in obstetrical and gynecological patients].
141. Acute-phase reactants.
142. Acute-phase reactants in sickle cell disease.
143. Acute-phase behavior of factor VIII procoagulant and other acute-phase reactants in rabbits.
144. Automated quantification of rat plasma acute phase reactants in experimental inflammation.
145. Altered expression of acute-phase reactants in mouse liver tumors.
146. Serine proteinase inhibitors as acute phase reactants in liver disease.
147. Concentrations of alpha-1-antichymotrypsin and other acute phase reactants in patients with gastric cancer.
148. Acute phase reactants in the elderly.
149. [Acute phase reactants--haptoglobin, transferrin, alpha 1-antitrypsin--in colorectal cancer].
150. Fever and acute phase reactants in the rat.
151. [Effects of cefotetan administration on acute phase reactants in patients in the field of obstetrics and gynecology].
152. Dexamethasone antagonism by RU 38486 in inflammatory reactions of the rat. Part 2: Biochemical parameters: RNA content of inflammation cells and acute phase reactants of the blood.
153. Acute phase reactants in inflammation and infection.
154. Proteinase inhibitors as acute phase reactants: regulation of synthesis and turnover.
155. Serum albumin, retinol-binding protein, thyroxin-binding prealbumin and acute phase reactants as indicators of undernutrition in children with undue susceptibility to acute infections.
156. Acute phase reactants and complement activation in patients with acute myocardial infarction.
157. Serum acute phase reactants in necrotizing enterocolitis.
158. Depression of tissue plasminogen activator (t-PA) activity and rise of t-PA inhibition and acute phase reactants in blood of patients with acute myocardial infarction (AMI).
159. Coin rubbing and acute phase reactants.
160. Soman intoxication-induced increase in the levels of mRNAs coding for acute phase reactants.
161. alpha-Fetoprotein and transcortin behave as acute phase reactants in the maternal and fetal compartments of the inflammatory pregnant mouse.
162. Complement in local biliary tract defense: dissociation between bile complement and acute phase reactants in cholecystitis.
163. Biochemical investigations after burning injury: complement system, protease-antiprotease balance and acute-phase reactants.
164. Enzymes and acute phase reactants in serum of selenium treated rats bearing adenocarcinoma.
165. Complete two-dimensional gel electrophoresis pattern of de novo synthesized acute phase reactants.
166. Purification of two species of exudate cysteine-proteinase inhibitors that are acute-phase reactants in the carrageenin-induced inflammation in rats.
167. Influence of chronic inflammation on the level of mRNA for acute-phase reactants in the mouse liver.
168. Acute phase reactants enhance CCl4 induced liver cirrhosis in the rat.
169. Acute phase reactants in the initial phase of giant cell arteritis.
170. Rheological importance of acute-phase reactants.
171. [Usefulness of acute phase reactants and albumin in the diagnosis of Crohn disease].
172. [Blood levels of acute phase reactants in threatened premature labor].
173. Response of the acute-phase reactants, C-reactive protein and serum amyloid A protein, to antibiotic treatment of Whipple's disease.
174. Immunological variables and acute-phase reactants in patients with ankylosing spondylitis (Bechterew's syndrome) and their relatives.
175. [Significance and clinical value of acute-phase reactants in bronchopulmonary cancer].
176. White blood cells and acute phase reactants in neonatal sepsis.
177. The acute phase response of mouse liver. Genetic analysis of the major acute phase reactants.
178. Monokine-induced hepatocyte synthesis of acute-phase reactants in mice.
179. Study of the evolution of acute phase reactants and of thromboxane and prostacyclin during calcium pyrophosphate-induced pleurisy in the rat.
180. Serum acute phase reactants in pediatric patients; especially in neonates.
181. Profiles of acute-phase reactants and clinical significance of alpha 2-macroglobulin in acute hepatitis B.
182. [Predictive value of acute phase reactants (APR)-score for perinatal infections].
183. A comparison of dye binding methods for albumin determination: the effects of abnormal sera, reaction times, acute phase reactants and albumin standards.
184. Changes in acute phase reactants and disturbances in metabolism after burn injury.
185. Correlation of hypercupremia with other acute phase reactants in malignant lymphoma.
186. [Changes of the blood sialic acid content and acute phase reactants in open heart surgery].
187. Serum protein pattern in normal pregnancy with special reference to acute-phase reactants.
188. Acute-phase reactants of mice. II. Strain dependence of serum amyloid P-component (SAP) levels and response to inflammation.
189. Dexamethasone regulation of alpha 1-acid glycoprotein and other acute phase reactants in rat liver and hepatoma cells.
190. Immunoassay of acute phase reactants and Latex-CRP as activity tests in chronic staphylococcal osteomyelitis.
191. Tests for platelet changes, acute phase reactants and serum lipids in diabetes mellitus and peripheral vascular disease.
192. [Clinical evaluation of plasma proteins in various renal diseases--with special reference to the changes in acute phase reactants of nephrotic syndrome (N.S.)].
193. [Clinical evaluation of plasma proteins in various renal diseases with special reference to the changes in acute phase reactants of glomerulonephritis and chronic renal failure. Part 1].
194. Quantification of acute phase reactants after muscle biopsy.
195. [Acute phase reactants in the serum of the patients with chronic liver diseases and its significance].
196. Acute phase reactants of mice. I. Isolation of serum amyloid P-component (SAP) and its induction by a monokine.
197. [Acute phase reactants activity and carcinoembryonic antigen in inflammatory intestinal disease (author's transl)].
198. Complement factors and acute phase reactants in the Guillain-Barré syndrome.
199. [Protector and prognostic value of acute phase reactants in meningococcal sepsis (author's transl)].
200. Can acute phase reactants distinguish benign and malignant disease of the upper gut?
201. Acute-phase reactants in experimental inhalation lung disease.
202. Immunofluorescent studies on acute phase reactants in patients with various types of chronic glomerulonephritis.
203. Immunologic tests of value in diagnosis. 1. Acute phase reactants and autoantibodies.
204. Secretion rate of intestinal immunoglobulins, complement factor C3, "acute phase" reactants, and albumin in the perfused ileum and jejunum of normal man.
205. A new enzymatic method for the determination of sialic acid in serum and its application for a marker of acute phase reactants.
206. Influence of an Indian medicine (Ashwagandha) on acute-phase reactants in inflammation.
207. Clinical usefulness of serum acute-phase reactants in patients with ovarian tumors.
208. Acute phase reactants and clinical stages in multiple myeloma.
209. The effect of alpha-difluoromethyl-ornithine on tumor growth, acute phase reactants, beta-2-microglobulin and hydroxyproline in kidney and bladder carcinomas.
210. Relationship of total serum sialic acid to sialylglycoprotein acute-phase reactants in malignant melanoma.
211. Alpha 2-Plasmin inhibitor is among acute phase reactants.
212. Alpha 1-antitrypsin and other acute phase reactants in liver disease.
213. Individual serum proteins and acute phase reactants in monoclonal immunoglobulinopathies. A study in patients with macroglobulinemia.
214. [Cell-mediated and humoral immunity in ulcerative colitis. Acute phase reactants (author's transl)].
215. Studies of host responses during experimental gingivitis in humans. II. Changes in acute phase reactants, serum immunoglobulins and complement during the development of gingival inflammation.
216. The protective effect of acute phase reactants in neonatal sepsis.
217. Serum proteinase inhibitors and acute-phase reactants from protein-energy malnutrition children during treatment.
218. Acute phase reactants and complement components as indicators of recurrence in human cervical cancer.
219. Pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG) and various acute phase reactants in rheumatoid arthritis and osteoarthritis.
220. Individual serum proteins and acute phase reactants in monoclonal immunoglobulinopathies (a study in patients with IgA myeloma and light chain myeloma).
221. Trace elements and acute phase reactants in gold treated rheumatoid arthritis patients.
222. Comparison of acute-phase reactants in pediatric patients with fever.
223. Relationships between abnormal IgG index, oligoclonal bands, acute phase reactants and some clinical data in multiple sclerosis.
224. Acute phase reactants ceruloplasmin and haptoglobin and their relationship to plasma prostaglandins in rabbits bearing the VS2 carcinoma.
225. Individual serum proteins and acute phase reactants in monoclonal immunoglobulinopathies (a study in patients with IgG myeloma).
226. Acute energy deprivation in man: effect on serum immunoglobulins antibody response, complement factors 3 and 4, acute phase reactants and interferon-producing capacity of blood lymphocytes.
227. The prognostic value of acute phase reactants in patients with neuroblastoma.
228. Acute-phase reactants of the blood in rat adjuvant arthritis as indicators of the degree of inflammation and of "specific" and unspecific anti-inflammatory effects.
229. [Pathophysiological analysis of acute phase reactants(I)--Clinical assessment of alpha2/alpha1 ratio obtained by serum protein electrophoresis (author's transl)].
230. Improved specificity of serum albumin determination and estimation of "acute phase reactants" by use of the bromcresol green reaction.
231. Effects of an oral enzyme preparation, Chymoral, upon serum proteins associated with injury (acute phase reactants) in man.
232. The assessment of rheumatoid arthritis. A study based on measurements of the serum acute-phase reactants.
233. Studies of acute phase reactants in myocardial infarction.
234. Acute-phase reactants and lysosomal enzymes in the blood of rats with experimental inflammation or radiation injury.
235. Studies on changes of several enzyme activities and of acute phase reactants in experimental allergic encephalomyelitis.
236. Synthesis and turnover of acute-phase reactants. In: Energy metabolism in trauma.
237. Immunoglobulins and acute phase reactants in man after major hepatic resection.
238. The effects of periodic challenge on the response of alpha-2-AP globulin and other acute-phase reactants of rat serum to tissue injury.
239. A study of serum copper and certain "acute-phase reactants" in alcoholics.
240. A study on correlation between C-reactive protein and certain other acute-phase reactants.
241. A study of some "acute phase reactants" in rheumatic diseases.
242. Protein-bound hexoses, glucosamine and other acute phase reactants in rheumatic fever.
243. Determination of some streptococcal antibody titers and acute phase reactants in patients with chorea.
244. Effect of intramuscular injections of benzathine penicillin G on some acute-phase reactants.
245. Diagnosis of rheumatic fever and like conditions; evaluation of certain of the acute phase reactants in a single specimen of blood.
246. An appraisal of certain acute phase reactants in a single blood sample and their value in the diagnosis of acute rheumatic fever.
247. The nephrotic syndrome in children. II. Observations concerning certain acute phase reactants.
248. Acute phase reactants. II. Serum hexosamines in patients with rheumatic fever and related diseases.
249. Acute phase reactants. I. Serum nonglucosamine polysaccharides in patients with rheumatic fever and related conditions.